Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
126.03
-1.64 (-1.28%)
Nov 13, 2024, 4:00 PM EST - Market closed
Ascendis Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 13, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 7,532 | 7,125 | 6,824 | 7,635 | 9,007 | 6,642 | |
| Market Cap Growth | 55.87% | 4.41% | -10.63% | -15.23% | 35.62% | 152.21% | |
| Enterprise Value | 8,073 | 7,347 | 6,449 | 6,676 | 7,922 | 5,964 | |
| Last Close Price | 127.67 | 125.95 | 122.13 | 134.53 | 166.78 | 139.12 | |
| PS Ratio | 21.30 | 24.17 | 124.77 | 863.17 | 1059.02 | 442.49 | |
| PB Ratio | -22.73 | -44.24 | 24.25 | 7.60 | 8.78 | 9.91 | |
| P/TBV Ratio | - | - | 24.70 | 7.64 | 8.84 | 9.97 | |
| EV/Sales Ratio | 23.72 | 24.92 | 117.92 | 754.73 | 931.41 | 397.32 | |
| Debt / Equity Ratio | -2.09 | -4.42 | 1.93 | 0.12 | 0.11 | 0.06 | |
| Asset Turnover | 0.40 | 0.28 | 0.05 | 0.01 | 0.01 | 0.03 | |
| Inventory Turnover | 0.22 | 0.26 | 0.12 | - | - | - | |
| Quick Ratio | 0.40 | 2.31 | 4.44 | 7.03 | 13.75 | 12.58 | |
| Current Ratio | 0.74 | 3.56 | 5.39 | 8.03 | 14.02 | 12.74 | |
| Return on Equity (ROE) | - | -818.43% | -101.69% | -44.54% | -58.36% | -49.71% | |
| Return on Assets (ROA) | -27.92% | -29.73% | -32.29% | -27.35% | -24.95% | -28.46% | |
| Return on Capital (ROIC) | -47.90% | -44.83% | -39.89% | -29.42% | -26.42% | -31.01% | |
| Earnings Yield | -6.96% | -7.47% | -9.13% | -5.71% | -5.69% | -3.68% | |
| FCF Yield | -4.65% | -7.29% | -7.99% | -6.57% | -3.96% | -3.06% | |
| Buyback Yield / Dilution | -1.33% | -0.38% | -2.37% | -8.21% | -8.84% | -13.20% | |
| Total Shareholder Return | -1.33% | -0.38% | -2.37% | -8.21% | -8.84% | -13.20% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.